A voluntary recall of RegenArouse – a “natural female intimacy enhancement” supplement – is being conducted by its maker, the FDA has announced.
Product: RegenArouse (Lot Number 130100)
Made By: Regeneca, Inc. distributed RegenArouse via sales made over the Internet to consumers in the United States of America and Puerto Rico between November 29, 2011 and February 10, 2012.
Why it’s being recalled: FDA lab analysis confirmed the presence of Tadalafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED). This may pose a threat to consumers because it may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. This active drug ingredient is not listed on the product’s label.
Description: RegenArouse, Lot Number 130100, is a pink capsule sold individually in foil packets, with the expiration date of 12/5/2013 and a UPC code of 816860010079.
Customers are advised to return any unused product for an exchange, or a full refund, to the company directly. Customers can call (800) 690-6958 (Monday through Friday from 8am to 6pm Pacific Time) for instructions on the return and exchange/refund process.
View the full recall on the FDA’s website here.
Comments